0000899243-15-003909.txt : 20150824
0000899243-15-003909.hdr.sgml : 20150824
20150824180614
ACCESSION NUMBER: 0000899243-15-003909
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150821
FILED AS OF DATE: 20150824
DATE AS OF CHANGE: 20150824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holmes Scott A
CENTRAL INDEX KEY: 0001537670
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 151071819
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-21
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001537670
Holmes Scott A
C/O KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
NEW YORK
NY
10022
0
1
0
0
Chief Financial Officer
Common Stock
2015-08-21
4
P
0
5000
5.718
A
54742
D
The reporting person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 2,758 shares, with the reporting person's sale of 2,758 shares of common stock at a price of $7.87 per share on July 31, 2015. The reporting person has agreed to pay Keryx $5,935.22, representing the full amount of the profit realized in connection with the short-swing transaction.
The reporting person effected multiple same-way open market purchase transactions on the same day at different prices, ranging from $5.717 to $5.72, through a trade order executed by a broker-dealer. The price reported in Column 4 is a weighted average price. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 45,000 shares of restricted stock.
/s/ Brian Adams
2015-08-24